Canopy Growth (CGC) Net Cash Flow (2019 - 2025)
Canopy Growth (CGC) reported Net Cash Flow of $187.5 million for Q4 2025, up 548.28% on a YoY basis from $28.9 million in Q4 2024, and up 1702.38% sequentially from $10.4 million in Q2 2025.
Canopy Growth (CGC) Net Cash Flow (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Net Cash Flow data on file, last reported at $187.5 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow rose 548.28% year-over-year to $187.5 million; the trailing twelve-month figure through Mar 2026 stood at $198.0 million (up 2111.7% YoY), and the FY2026 full-year result was $180.3 million, up 498.76% from the prior year.
- Net Cash Flow rose to $187.5 million in Q4 2025, from $10.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $270.7 million in Q1 2021 to a low of -$476.2 million in Q2 2021.
- A 5-year average of -$8.0 million and a median of $5.4 million in 2024 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow tumbled 238.26% in 2023 and jumped 548.28% in 2025, its largest moves.
- Tracing CGC's Net Cash Flow over 5 years: stood at -$152.2 million in 2021, then advanced by 5.87% to -$143.3 million in 2022, then jumped by 49.03% to -$73.0 million in 2023, then jumped by 42.7% to -$41.8 million in 2024, then soared by 548.28% to $187.5 million in 2025.
- Business Quant data shows CGC's Net Cash Flow at $187.5 million in Q4 2025, $10.4 million in Q2 2025, and -$41.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 187.55 Mn |
| Dec 31, 2025 | 187.55 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Dec 31, 2024 | -41.84 Mn |
| Dec 31, 2024 | -41.84 Mn |
| Sep 30, 2024 | 24.09 Mn |
| Sep 30, 2024 | 24.09 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | -73.02 Mn |
| Dec 31, 2023 | -73.02 Mn |
| Sep 30, 2023 | -250.00 Mn |
| Sep 30, 2023 | -250.00 Mn |
| Jun 30, 2023 | -72.03 Mn |
| Jun 30, 2023 | -72.03 Mn |
| Mar 31, 2023 | 178.17 Mn |
| Mar 31, 2023 | 178.17 Mn |